Article Details

Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

Retrieved on: 2025-09-18 23:02:21

Tags for this article:

Click the tags to see associated articles and topics

Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety. View article details on hiswai:

Excerpt

... monoclonal antibody. 1-3. "In this phase 2 trial, the intent was to utilize consolidative therapy post-standard care ide-cel," Matthew Lei, PharmD ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo